Gene Therapy for Hemophilia B With Liver-specific Element Mediated by Rep-RBE Site-specific Integration System

Gene Therapy for Hemophilia B With Liver-specific Element Mediated by Rep-RBE Site-specific Integration System
复制标题

Rep-RBE 位点特异性整合系统介导的肝脏特异性元件对 B 型血友病的基因治疗

DOI:
10.1097/fjc.0000000000000172
复制
发表时间:
2014-10
影响因子:
3
通讯作者:
薛京伦
薛京伦
中科院分区:
医学4区
文献类型:
--
作者:
张阿敏;谢林俊;沈琦;薛京伦

文献摘要

参考文献

相似文献

摘要:腺相关病毒(Adeno-associated virus, AAV)是一种非致病性病毒,能够靶向人类19号染色体的AAVS1位点进行整合,在AAV调节蛋白(Rep)存在的情况下,AAV的16 bp Rep结合元件(RBE)序列足以介导这种特异性整合。在此之前,我们通过水动力注射将2个质粒pRBE-CMV-hFIX和pRC共转导到AAVS1转基因小鼠体内,观察了人凝血因子IX (human coagulation Factor IX, hFIX)的长期表达。通过巢式聚合酶链反应验证相应的AAVS1位点特异性整合。在这项研究中,我们建立了一个新的hFIX表达质粒,pRBE-HCR-hAAT-hFIX,由肝脏特异性启动子驱动,用HCR-hAAT组成的人源化启动子取代pRBE-CMV-hFIX的CMV启动子。瞬时转染pRBE-CMV-hFIX或pRBE-HCR-hAAT-hFIX后,hFIX在体外的表达几乎相同。在转染pRC/pRBE-CMV-hFIX鸡尾酒和pRC/pRBE-HCR-hAAT-hFIX鸡尾酒的小鼠中均发现了aavs1特异性整合。然而,pRBE-HCR-hAAT-hFIX小鼠的hFIX表达更高,持续时间更长。达到正常血浆hFIX浓度的1%以上,并维持240天。结果表明,RBE-HCR-hAAT元件可以提高hFIX的表达,并显示Rep-RBE位点特异性整合在血友病B基因治疗中的潜在应用。
Abstract: Adeno-associated virus (AAV) is a nonpathogenic virus capable of targeting human chromosome 19 for integration at AAVS1 site, and a 16 bp Rep binding element (RBE) sequence of AAV was sufficient for mediating this specific integration in the presence of AAV regulation proteins (Rep). Previously, we cotransduced 2 plasmids, pRBE-CMV-hFIX and pRC, into the AAVS1 transgenic mice by hydrodynamic injection, and a long-term expression of human coagulation Factor IX (hFIX) was observed. The corresponding AAVS1 locus site-specific integrations were verified by nested polymerase chain reaction. In this study, we established a novel hFIX expression plasmid, pRBE-HCR-hAAT-hFIX, driven by a liver-specific promoter by replacing the CMV promoter of pRBE-CMV-hFIX with a humanized promoter consisting of HCR-hAAT. The expression of hFIX in vitro was almost the same in transient transfection of pRBE-CMV-hFIX or pRBE-HCR-hAAT-hFIX. AAVS1-specific integrations were identified both in mice transfected with pRC/pRBE-CMV-hFIX cocktail and pRC/pRBE-HCR-hAAT-hFIX cocktail. However, the expression of hFIX of pRBE-HCR-hAAT-hFIX mice was higher and persisted longer. It achieved more than 1% of normal plasma hFIX concentration and maintained for 240 days. The result suggested that RBE-HCR-hAAT element could improve the expression of hFIX and present potential usage of Rep-RBE site-specific integration in gene therapy for hemophilia B.
DOI: 10.1038/mt.2008.161
发表时间: 2008-10
期刊: Molecular therapy : the journal of the American Society of Gene Therapy
影响因子: --
作者:
通讯作者: --
DOI: 10.1126/science.8211118
发表时间: 1993-10-01
期刊: SCIENCE
影响因子: 56.9
作者:
KAY, MA;ROTHENBERG, S;WOO, SLC
通讯作者: WOO, SLC
DOI: 10.1021/bp070319o
发表时间: 2008-07-01
影响因子: 2.9
作者:
Douglas, Kimberly L.
通讯作者: Douglas, Kimberly L.
DOI: 10.1038/sj.gt.3301229
发表时间: 2000-08-01
期刊: GENE THERAPY
影响因子: 5.1
作者:
Zhang, G;Song, YK;Liu, D
通讯作者: Liu, D
DOI: 10.1002/jgm.1583
发表时间: 2011-07
期刊: The Journal of Gene Medicine
影响因子: --
作者:
H. Kim;Jong Chul Kim;Yeon Kyung Lee;Jung Seok Kim;Y. Park
通讯作者: H. Kim;Jong Chul Kim;Yeon Kyung Lee;Jung Seok Kim;Y. Park